NCT02180958View on ClinicalTrials.gov

Evaluation of ONYX in ENDOVASCULAR Treatment of Cerebral AVMs

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Cerebral Arteriovenous Malformations
Trial Locations (17)

Unknown

CHU Besançon, Besançon

Chu Pellegrin, Bordeaux

CHU Côte de Nacre, Caen

CHU Gabriel Montpied, Clermont-Ferrand

CHI Dijon, Dijon

CHP Clairval, Marseille

Hôpital GUI DE CHAULLAC, Montpellier

CHU Nantes, Nantes

Fondation Ophtamoligique Rothschild, Paris

Groupe Hospitalier Pitier Salpetrière, Paris

Hôpital Beaujon, Paris

Hôpital Bicêtre, Paris

CHU Pontchaillou, Rennes

CHU Strasbourg, Strasbourg

HIA Sainte Anne, Toulon

CHU Toulouse, Toulouse

CHRU Tours, Tours

All Listed Sponsors
lead

Medtronic Neurovascular Clinical Affairs

INDUSTRY

NCT02180958 - Evaluation of ONYX in ENDOVASCULAR Treatment of Cerebral AVMs | Biotech Hunter | Biotech Hunter